Solid Subtype Predicts Early Bone Metastases in Sensitive EGFR-Mutated Lung Adenocarcinoma Patients After Surgery

被引:0
|
作者
Xiong, A. [1 ]
Li, C. [1 ]
Xu, J. [1 ]
Yang, X. [1 ]
Nie, W. [1 ]
Zhong, H. [1 ]
Chu, T. [1 ]
Zhang, W. [1 ]
Zhong, R. [1 ]
Pan, F. [1 ]
Shen, Y. [1 ]
Lou, Y. [1 ]
Zhang, B. [1 ]
Han, B. [1 ]
Zhang, X. [1 ]
机构
[1] Shanghai Chest Hosp, Shanghai, Peoples R China
关键词
Histologic subtype; non-small cell lung cancer; Distant metastasis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
FP12.06
引用
收藏
页码:S966 / S967
页数:2
相关论文
共 27 条
  • [1] Solid subtype predicts early bone metastases in sensitive EGFR-mutated lung adenocarcinoma patients after surgery
    Xiong, Anning
    Li, Changhui
    Xu, Jianlin
    Yang, Xiaohua
    Nie, Wei
    Zhong, Hua
    Chu, Tianqing
    Zhang, Wei
    Zhong, Runbo
    Pan, Feng
    Shen, Yinchen
    Lou, Yuqing
    Zhang, Bo
    Han, Baohui
    Zhang, Xueyan
    LUNG CANCER, 2021, 154 : 124 - 130
  • [2] High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases
    Lagana, Marta
    Gurizzan, Cristina
    Roca, Elisa
    Cortinovis, Diego
    Signorelli, Diego
    Pagani, Filippo
    Bettini, Anna
    Bonomi, Lucia
    Rinaldi, Silvia
    Berardi, Rossana
    Filetti, Marco
    Giusti, Raffaele
    Pilotto, Sara
    Milella, Michele
    Intagliata, Salvatore
    Baggi, Alice
    Cortellini, Alessio
    Soto Parra, Hector
    Brighenti, Matteo
    Petrelli, Fausto
    Bennati, Chiara
    Bidoli, Paolo
    Garassino, Marina Chiara
    Berruti, Alfredo
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [3] Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib
    Ying Yuan
    Chunwen Tan
    Modan Li
    Hong Shen
    Xuefeng Fang
    Yinghong Hu
    Shenglin Ma
    World Journal of Surgical Oncology, 10
  • [4] Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib
    Yuan, Ying
    Tan, Chunwen
    Li, Modan
    Shen, Hong
    Fang, Xuefeng
    Hu, Yinghong
    Ma, Shenglin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
  • [5] Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs
    Qi Gui
    Jiangang Liu
    Dapeng Li
    Chengcheng Xu
    World Journal of Surgical Oncology, 15
  • [6] Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs
    Gui, Qi
    Liu, Jiangang
    Li, Dapeng
    Xu, Chengcheng
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2017, 15
  • [7] A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer
    Wu, Yi-Long
    Tsuboi, Masahiro
    John, Thomas
    Grohe, Christian
    Majem, Margarita
    Goldman, Jonathan W.
    Laktionov, Konstantin
    Kim, Sang-We
    Kato, Terufumi
    Huu-Vinh Vu
    Lu, Shun
    Lee, Kye-Young
    Akewanlop, Charuwan
    Yu, Chong-Jen
    de Marinis, Filippo
    Bonanno, Laura
    Domine, Manuel
    Shepherd, Frances A.
    Zeng, Lingmin
    Hodge, Rachel
    Atasoy, Ajlan
    Rukazenkov, Yuri
    Herbst, Roy S.
    FUTURE ONCOLOGY, 2021, 17 (35) : 4827 - 4835
  • [8] Treatment Patterns and Clinical Outcomes in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer After Progression on Osimertinib
    Robinson, Nathaniel D.
    Canavan, Maureen E.
    Zhan, Peter L.
    Udelsman, Brooks, V
    Pathak, Ranjan
    Boffa, Daniel J.
    Goldberg, Sarah B.
    CLINICAL LUNG CANCER, 2025, 26 (01)
  • [9] Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with EGFR-mutated non-small-cell lung cancer: a retrospective, multicenter cohort study
    Tanaka, Ichidai
    Hori, Kazumi
    Koyama, Junji
    Gen, Soei
    Morise, Masahiro
    Kodama, Yuta
    Matsui, Akira
    Miyazawa, Ayako
    Hase, Tetsunari
    Hibino, Yoshitaka
    Yokoyama, Toshihiko
    Kimura, Tomoki
    Yoshida, Norio
    Sato, Mitsuo
    Ishii, Makoto
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [10] Micropapillary and/or Solid Histologic Subtype Based on Pre-Treatment Biopsy Predicts Local Recurrence After Thermal Ablation of Lung Adenocarcinoma
    Gao, Song
    Stein, Seth
    Petre, Elena N.
    Shady, Waleed
    Durack, Jeremy C.
    Ridge, Carole
    Adusumilli, Prasad
    Rekhtman, Natasha
    Solomon, Stephen B.
    Ziv, Etay
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (02) : 253 - 259